GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Turk Ilac ve Serum Sanayi (IST:TRILC) » Definitions » Gross-Profit-to-Asset %

Turk Ilac ve Serumnayi (IST:TRILC) Gross-Profit-to-Asset % : 19.70% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Turk Ilac ve Serumnayi Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Turk Ilac ve Serumnayi's annualized Gross Profit for the quarter that ended in Sep. 2023 was ₺276 Mil. Turk Ilac ve Serumnayi's average Total Assets over the quarter that ended in Sep. 2023 was ₺1,400 Mil. Therefore, Turk Ilac ve Serumnayi's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 was 19.70%.


Turk Ilac ve Serumnayi Gross-Profit-to-Asset % Historical Data

The historical data trend for Turk Ilac ve Serumnayi's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turk Ilac ve Serumnayi Gross-Profit-to-Asset % Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 35.62 30.64 29.75 23.63 25.01

Turk Ilac ve Serumnayi Quarterly Data
Dec17 Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.82 21.43 20.70 28.63 19.70

Competitive Comparison of Turk Ilac ve Serumnayi's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Turk Ilac ve Serumnayi's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Turk Ilac ve Serumnayi's Gross-Profit-to-Asset % falls into.



Turk Ilac ve Serumnayi Gross-Profit-to-Asset % Calculation

Turk Ilac ve Serumnayi's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=208.1/( (619.53+1044.339)/ 2 )
=208.1/831.9345
=25.01 %

Turk Ilac ve Serumnayi's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=275.944/( (1195.404+1605.532)/ 2 )
=275.944/1400.468
=19.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Turk Ilac ve Serumnayi Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Turk Ilac ve Serumnayi's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Turk Ilac ve Serumnayi (IST:TRILC) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Bügduz Mah. Enver Pasa Cad., No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.

Turk Ilac ve Serumnayi (IST:TRILC) Headlines

No Headlines